Immunic
IMUX
$1.55
Share price
1.83%
Change (1 day)
-33.77%
Change (1 year)
Categories
Earnings for Immunic (IMUX)
Earnings in 2024 (TTM): -NZ$0.17 Billion
According to Immunic's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunic from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -NZ$0.17 Billion | -1.18% |
| 2023 | -NZ$0.18 Billion | 14.68% |
| 2022 | -NZ$0.15 Billion | -5.62% |
| 2021 | -NZ$0.16 Billion | 87.18% |
| 2020 | -NZ$84.06 Million | 32.24% |
| 2019 | -NZ$63.57 Million | -9.25% |
| 2018 | -NZ$70.04 Million | -22.5% |
| 2017 | -NZ$90.38 Million | 27.6% |
| 2016 | -NZ$70.83 Million | -20.82% |
| 2015 | -NZ$89.46 Million | 9.34% |
| 2014 | -NZ$81.82 Million | 33.05% |
| 2013 | -NZ$61.5 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -NZ$0.25 Billion | 45.73% | 🇺🇸 USA |